ISPON President Calls for Collaboration to Improve Safety

The International Society of Pharmacovigilance (ISOPN) President has issued a public call for increased collaboration among regulators, pharmaceutical companies, healthcare professionals, and patient groups to strengthen drug‑safety monitoring worldwide. The appeal emphasizes sharing real‑time safety data, harmonising reporting standards, expanding use of advanced analytics, and fostering joint training programs to detect adverse drug reactions earlier and improve patient protection. Views Nigeria